353810 Stock Chart & Stats
₩5930.00
₩200.00(3.49%)
―
--
Day’s Range― - ―
52-Week Range₩5,100.00 - ₩8,560.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)86.65K
Market Cap
₩189.56B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)5.7
Beta-0.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding33,081,920
10 Day Avg. Volume74,688
30 Day Avg. Volume86,654
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,838,472.83
Revenue Forecast (FY)₩10.00T>
353810 FAQ
What was EASY BIO, Inc.’s price range in the past 12 months?
EASY BIO, Inc. lowest stock price was ₩5100.00 and its highest was ₩8560.00 in the past 12 months.
What is EASY BIO, Inc.’s market cap?
EASY BIO, Inc.’s market cap is ₩189.56B.
When is EASY BIO, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were EASY BIO, Inc.’s earnings last quarter?
EASY BIO, Inc. released its earnings results on May 15, 2026. The company reported ₩338.182 earnings per share for the quarter, beating the consensus estimate of N/A by ₩338.182.
Is EASY BIO, Inc. overvalued?
According to Wall Street analysts EASY BIO, Inc.’s price is currently Undervalued.
Does EASY BIO, Inc. pay dividends?
EASY BIO, Inc. does not currently pay dividends.
What is EASY BIO, Inc.’s EPS estimate?
EASY BIO, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EASY BIO, Inc. have?
EASY BIO, Inc. has 33,081,920 shares outstanding.
What happened to EASY BIO, Inc.’s price movement after its last earnings report?
EASY BIO, Inc. reported an EPS of ₩338.182 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.365%.
Which hedge fund is a major shareholder of EASY BIO, Inc.?
Currently, no hedge funds are holding shares in KR:353810
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC CELL CORPORATION
―
Boditech Med, Inc.
―
KANGSTEM BIOTECH Co., Ltd.
―
Curacle Co., Ltd.
―
NeoImmuneTech Inc shs Korean Deposit Receipt Repr 1/5 Sh
―